Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • GSK-3
    (4)
  • CDK
    (2)
  • Apoptosis
    (1)
  • IGF-1R
    (1)
  • JAK
    (1)
  • MEK
    (1)
  • ROCK
    (1)
  • Raf
    (1)
  • S6 Kinase
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

gsk 25

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    9
    TargetMol | Inhibitors_Agonists
gsk-25
GSK25
T4488874119-56-9
GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
GSK-3β inhibitor 25
T20450175620-25-6
GSK-3β inhibitor25 (Compound 6h) exhibits weak inhibitory activity against GSK-3β with an IC50 greater than 100 μM.
  • Inquiry Price
10-14 weeks
Size
QTY
5-Iodo-indirubin-3'-monoxime
T10172331467-03-9In house
5-Iodo-indirubin-3'-monoxime is a potent inhibitor of GSK-3β, CDK5 P25, and CDK1 cyclin B, competing with ATP for binding to the catalytic site of the kinase (IC50s: 9, 20, and 25 nM).
  • Inquiry Price
6-8 weeks
Size
QTY
GSK1904529A
GSK 4529
T60031089283-49-7In house
GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) .
  • Inquiry Price
7-10 days
Size
QTY
TargetMol | Citations Cited
GSK-114
T223411301761-96-5
GSK-114, a selective inhibitor of TNNI3 Interacting Kinase (TNNI3K) with IC50 of 25 nM, shows significant bias for TNNI3K over B-Raf with IC50 of 1000 nM, exceptional broad spectrum kinase selectivity and adequate oral exposure to enable its use in cellul
  • Inquiry Price
Size
QTY
RGB-286638 free base
T2378784210-88-4
RGB-286638 free base is a novel CDK inhibitor with IC50s of 1 nM 2 nM 3 nM 4 nM 5 nM for cyclin T1-CDK9 cyclin B1-CDK1 cyclin E-CDK2 cyclin D1-CDK4 cyclin E-CDK3 p35-CDK5 respectively; less potent against cyclin H-CDK7 and cyclin D3-CDK6.
  • Inquiry Price
Size
QTY
GSK-3β inhibitor 12
T60472784170-07-6
GSK-3β inhibitor 12 is a selective GSK-3β inhibitor.GSK-3β inhibitor 12 inhibits 49.11% of 25 μM GSK-3β activity and 37.11% of 50 μM GSK-3β activity.GSK-3β inhibitor 12 can be used for the study of Parkinson's in the presence of lipopolysaccharide induction.
  • Inquiry Price
6-8 weeks
Size
QTY
zdwx-25
T607482668297-70-7
ZDWX-25 is a highly potent dual inhibitor of GSK-3β and DYRK1A, exhibiting significant cytotoxic activities towards SH-SY5Y and HL-7702 cells, and an IC 50 value of 71 nM for GSK-3β [1]. ZDWX-25 can be used for Alzheimer's disease research.
  • Inquiry Price
6-8 weeks
Size
QTY
RGB-286638
T73196784210-87-3
RGB-286638 is a multi-target CDK inhibitor that effectively hampers the kinase activity of a range of cyclin-CDK complexes, including cyclin T1-CDK9 (IC50 = 1 nM), cyclin B1-CDK1 (IC50 = 2 nM), cyclin E-CDK2 (IC50 = 3 nM), cyclin D1-CDK4 (IC50 = 4 nM), cyclin E-CDK3 (IC50 = 5 nM), and p35-CDK5 (IC50 = 5 nM). Additionally, it inhibits other kinases such as GSK-3β (IC50 = 3 nM), TAK1 (IC50 = 5 nM), Jak2 (IC50 = 50 nM), and MEK1 (IC50 = 54 nM), showcasing its versatile inhibitory potential.
  • Inquiry Price
10-14 weeks
Size
QTY